MEDRANO, J. V., Ivana AĆIMOVIĆ, A. NAVARRO-GOMEZLECHON, I. NOGUERA, A. PELLICER, M. M. ANDRES a E. NOVELLA-MAESTRE. Timing of spermatogonial stem cell transplantation affects the spermatogenic recovery outcome in mice. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL. NEW YORK: SPRINGER, 2021, roč. 57, č. 1, s. 21-29. ISSN 1071-2690. Dostupné z: https://dx.doi.org/10.1007/s11626-020-00531-9.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Timing of spermatogonial stem cell transplantation affects the spermatogenic recovery outcome in mice
Autoři MEDRANO, J. V. (garant), Ivana AĆIMOVIĆ (688 Srbsko, domácí), A. NAVARRO-GOMEZLECHON, I. NOGUERA, A. PELLICER, M. M. ANDRES a E. NOVELLA-MAESTRE.
Vydání IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, NEW YORK, SPRINGER, 2021, 1071-2690.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10601 Cell biology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.723
Kód RIV RIV/00216224:14110/21:00121703
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s11626-020-00531-9
UT WoS 000606180100002
Klíčová slova anglicky Fertility preservation; Spermatogonial stem cell transplantation; Spermatogenic recovery; Gonadotoxic onset; Timing
Štítky 14110513, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 3. 6. 2021 08:26.
Anotace
Spermatogonial stem cell transplantation (SSCT) is a strategy that has demonstrated to be feasible to restore spermatogenesis in animal models when it is performed shortly after the gonadotoxic onset to destroy their endogenous germ cells. However, in the case of boys subjected to fertility preservation, future transplantations will be performed with a delay of many years. In order to study how timing of SSCT affects donor-derived spermatogenic recovery in mice, we compared the percentage of spermatogenic tubule cross-sections within testes of 59 C57BL/6NCrl mice distributed in 6 groups: group 1, untreated mice controls (n = 9); group 2, mice that received a single dose of busulfan 40 mg/kg (n = 10); group 3, mice that received two additional doses of busulfan 10 mg/kg every 5 weeks (n = 10); group 4 (SSCT-A), mice subjected to a standard SSCT performed 5 weeks after a single injection of busulfan 40 mg/kg (n = 10); group 5 (SSCT-B), mice subjected to a delayed SSCT performed 15 weeks after a single injection of busulfan 40 mg/kg (n = 10); and group 6 (SSCT-C), mice subjected to a delayed SSCT with two additional doses of busulfan 10 mg/kg every 5 weeks (n = 10). Spermatogenic recovery in standard SSCT-A and SSCT-C groups ranged between 22.29 and 22.65%, compared with a lower recovery rate of 11.54% showed in the SSCT-B group. However, donor contribution resulted higher in standard SSCT-A, representing a 69.71% of cross-sections, compared with the rest of conditions ranging from 34.69 to 35.42%. Overall, we concluded that a delay in the SSCT from the gonadotoxic onset decreases the efficiency of donor-derived spermatogenic recovery in mice.
VytisknoutZobrazeno: 8. 5. 2024 13:24